D-0637-2024 Class II Ongoing
FDA drug recall D-0637-2024 was initiated by Teva Pharmaceuticals USA, Inc on Aug 8, 2024 and is designated Class II. Reason for recall: Superpotent Drug The recall status is ongoing. Affected quantity: 7,080 unit dose packets.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 28, 2024
- Initiation Date
- Aug 8, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 7,080 unit dose packets
Product description
Testosterone Gel, 1.62%, (Alcohol 80% v/v), 30 unit-dose packets, Rx Only, Teva Pharmaceuticals, USA, Inc. North Wales, PA 19454, NDC 0591-2925-30. Packet NDC # 0591-2925-32 Carton NDC # 0591-2925-30
Reason for recall
Superpotent Drug
Distribution pattern
Product was distributed nationwide within the United States
Code information
Lot #: 100042386, Exp. Date 06/2025
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0637-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026